Table of Contents
ISRN Pediatrics
Volume 2013 (2013), Article ID 932697, 7 pages
http://dx.doi.org/10.1155/2013/932697
Clinical Study

Prevalence and Clinical and Immunoviralogical Profile of Human Immunodeficiency Virus-Hepatitis B Coinfection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria

1Department of Paediatrics, Federal Medical Centre, PMB 12245, Makurdi, Benue State, Nigeria
2Center for Clinical Care and Clinical Research, 29 Mambilla Street, Off Aso Drive, Maitama, Abuja, Nigeria

Received 25 February 2013; Accepted 17 March 2013

Academic Editors: M. Adhikari, G. J. Casimir, J. A. O'Neill, and G. K. Siberry

Copyright © 2013 Emmanuel Ademola Anigilaje and Ayodotun Olutola. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Global HIV/AIDS Response, “Epidemic update and health sector progress towards Universal Access,” Progress Report, 2011. View at Google Scholar
  2. Federal Ministry of Health, ANC HIV Sentinel Survey, Federal Ministry of Health, Abuja, Nigeria, 2010.
  3. Federal Ministry of Health, National Guidelines for Paediatric HIV and AIDS Treatment and Care, Federal Ministry of Health, Abuja, Nigeria, 2007.
  4. A. Ojoawo, O. Dairo, and A. Ojetunde, Eds., City Profile of HIV/AIDS in the City of Makurdi, Nigeria, The Development Policy Centre, Ibadan, Nigeria, 2005.
  5. World Health Organization, Introduction of Hepatitis B into Childhood Immunization Services: Management Guidelines, Including Information for Health Workers and Parents, World Health Organization, Geneva, Switzerland, 2001.
  6. A. E. Sadoh, W. E. Sadoh, and N. J. Iduoriyekemwen, “HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme,” SAJCH South African Journal of Child Health, vol. 5, supplement 1, pp. 7–10, 2011. View at Google Scholar · View at Scopus
  7. H. Rawizza, S. Ochigbo, C. Chang et al., “Prevalence of hepatitis co-infection among HIV infected Nigerian children in the Harvard PEPFAR ART program,” in Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, NC, USA, February 2010, Poster abstract S-181, http://retroconference.org/2010/Abstracts/39148.htm.
  8. G. M. Ashir, A. I. Rabasa, M. M. Gofama, D. Bukbuk, H. Abubakar, and G. A. Farouk, “Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection,” Nigerian Journal of Medicine, vol. 18, supplement 30, pp. 260–262, 2009. View at Google Scholar · View at Scopus
  9. F. Rouet, M. L. Chaix, A. Inwoley et al., “Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1 infected children,” Clinical Infectious Diseases, vol. 46, no. 3, pp. 361–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. M. Mbaawuaga, M. N. O. Enenebeaku, J. A. Okopi, and J. G. Damen, “Hepatitis B Virus (HBV) infection among pregnant women in Makurdi, Nigeria,” African Journal Biomedical Research, vol. 11, no. 2, pp. 155–159, 2008. View at Google Scholar · View at Scopus
  11. J. F. Colin, D. Cazals-Hatem, M. A. Loriot et al., “Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men,” Hepatology, vol. 29, no. 4, pp. 1306–1310, 1999. View at Google Scholar · View at Scopus
  12. H. Oshitani, F. C. Kasolo, M. Mpabalwani et al., “Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 3, pp. 235–236, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Mendy, T. Welzel, O. A. Lesi et al., “Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in the Gambia, West Africa,” Journal of Viral Hepatitis, vol. 17, supplement 2, pp. 115–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. F. Yuen, Y. Tanaka, D. Y. T. Fong et al., “Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B,” Journal of Hepatology, vol. 50, no. 1, pp. 80–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Eskild, P. Magnus, G. Petersen et al., “Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS,” AIDS, vol. 6, no. 6, pp. 571–574, 1992. View at Google Scholar · View at Scopus
  16. R. J. C. Gilson, A. E. Hawkins, M. R. Beecham et al., “Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection,” AIDS, vol. 11, no. 5, pp. 597–606, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Livry, C. Binquet, C. Sgro et al., “Acute liver enzyme elevations in HIV-1-infected patients,” HIV Clinical Trials, vol. 4, no. 6, pp. 400–410, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Puoti, C. Torti, D. Ripamonti et al., “Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome,” Journal of Acquired Immune Deficiency Syndromes, vol. 32, no. 3, pp. 259–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. HIV/AIDS, Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access. Recommendations for a Public Health Approach: 2010 Revision, 2010.
  20. S. P. Telatela, M. I. Matee, and E. K. Munubhi, “Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania,” BMC Public Health, vol. 7, p. 338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. S. Toussi, J. Abadi, M. Rosenberg, and D. Levanon, “Prevalence of hepatitis B and C virus infections in children infected with HIV,” Clinical Infectious Diseases, vol. 45, no. 6, pp. 795–798, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Chakraborty, G. Rees, D. Bourboulia et al., “Viral coinfections among African children infected with human immunodeficiency virus type 1,” Clinical Infectious Diseases, vol. 36, no. 7, pp. 922–924, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Zhou, Y. Zhao, Y. He et al., “Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009,” Journal of Acquired Immune Deficiency Syndromes, vol. 54, supplement 2, pp. 191–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Jafri, N. Jafri, J. Yakoob et al., “Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan,” BMC Infectious Diseases, vol. 6, p. 101, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. E. I. Ugwuja and N. C. Ugwu, “Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria,” Internet Journal of Tropical Medicine, vol. 6, no. 1, p. 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Ndako, G. O. N. Echeonwu, A. O. Olabode et al., “Seroprevalence of hepatitis B surface antigen (HBsAg) among children of primary school age in a community, North-Central, Nigeria,” Sierra Leone Journal of Biomedical Research, vol. 2, supplement 1, pp. 32–37, 2010. View at Google Scholar
  27. I. A. Angyo and A. M. Yakubu, “Lack of association between some risk factors and hepatitis B surface antigenaemia in children with sickle cell anaemia,” West African Journal of Medicine, vol. 20, supplement 3, pp. 214–218, 2001. View at Google Scholar · View at Scopus
  28. D. N. Bukbuk, A. P. Bassi, and Z. M. Mangoro, “Sero-prevalence of hepatitis B surface antigen among primary school pupils in rural Hawal valley, Borno State, Nigeria,” J Comm Med PHC, vol. 17, supplement 1, pp. 20–23, 2005. View at Google Scholar
  29. WHOUNICEF, “Estimatesofhepb3. coverage,” 2012, http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tswucoveragehepb3.htm. View at Google Scholar
  30. M. S. Sulkowski, D. L. Thomas, R. E. Chaisson, and R. D. Moore, “Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection,” Journal of the American Medical Association, vol. 283, no. 1, pp. 74–80, 2000. View at Google Scholar · View at Scopus
  31. G. J. Dore, D. A. Cooper, C. Barrett, L. E. Goh, B. Thakrar, and M. Atkins, “Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR),” Journal of Infectious Diseases, vol. 180, no. 3, pp. 607–613, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. G. V. Matthews, A. Bartholomeusz, S. Locarnini et al., “Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy,” AIDS, vol. 20, no. 6, pp. 863–870, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. “HIV and hepatitis B co-infection,” in Background Document, A. E. Singh and T. Wong, Eds., pp. 1–43, 2009.
  34. “Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection,” 2012, http://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf.